Literature DB >> 2251337

Extinction and reacquisition of differential responding in rats trained to discriminate between chlordiazepoxide and saline.

H J Rijnders1, T U Järbe, J L Slangen.   

Abstract

In order to assess the resistance of drug discriminative responding to prolonged reinforcement omission, rats were trained to discriminate between either 6.0 mg/kg PO or 30.0 mg/kg PO. CDP and saline, using a food reinforced (V140-FR10) operant procedure. Dose generalization tests were conducted for both groups. Sessions were then run without reinforcement while drug (D) and saline (S) administrations were continued (extinction phase). After a maximum of 30 sessions without reinforcement, or when the rats emitted less than ten responses on either lever during three successive sessions (extinction criterion), reinforcement was reinstated. Finally, additional dose generalization tests with CDP were run. The discriminative responding controlled by the D and S administrations was not affected significantly by prolonged reinforcement omission in either group. For both groups, response rates were decreased and latencies to initiate responding were increased during the extinction phase. Response rate reduction occurred more rapidly for the drug condition in the high training dose group. This group also reached the extinction criterion sooner than the low training dose group. The reacquisition process occurred very rapidly. Response rates increased substantially after the first reinforcement had been obtained. After ten reacquisition sessions, response rates and latencies had reached values similar to those observed before extinction was initiated. Data revealed no differences between groups and the course of reacquisition did not differ between the S and D conditions.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2251337     DOI: 10.1007/bf02244111

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  4 in total

1.  Effects of training dose on discrimination and cross-generalization of chlordiazepoxide, pentobarbital and ethanol in the rat.

Authors:  J De Vry; J L Slangen
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  Retroactive interference in discrimination learning.

Authors:  E G Heinemann; J Sage-Day; N Brenner
Journal:  Science       Date:  1981-12-11       Impact factor: 47.728

3.  Factors regulating drug cue sensitivity: the effect of training dose in fentanyl-saline discrimination.

Authors:  F C Colpaert; C J Niemegeers; P A Janssen
Journal:  Neuropharmacology       Date:  1980-08       Impact factor: 5.250

4.  Forgetting of a drug-conditional discrimination.

Authors:  N E Spear; G J Smith; A Sherr; R G Bryan
Journal:  Physiol Behav       Date:  1979-05
  4 in total
  6 in total

1.  Reversal of overshadowing in a drug mixture discrimination in rats.

Authors:  J A White; I P Stolerman
Journal:  Psychopharmacology (Berl)       Date:  1996-01       Impact factor: 4.530

2.  Drug discrimination: stimulus control during repeated testing in extinction.

Authors:  T J Zarcone; N A Ator
Journal:  J Exp Anal Behav       Date:  2000-11       Impact factor: 2.468

3.  Facilitation by drug states does not depend on acquired excitatory strength.

Authors:  Matthew I Palmatier; Rick A Bevins
Journal:  Behav Brain Res       Date:  2006-11-07       Impact factor: 3.332

4.  The discriminative stimulus properties of buspirone involve dopamine-2 receptor antagonist activity.

Authors:  H J Rijnders; J L Slangen
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

5.  Occasion setting by drug states: Functional equivalence following similar training history.

Authors:  Matthew I Palmatier; Rick A Bevins
Journal:  Behav Brain Res       Date:  2008-09-18       Impact factor: 3.332

6.  Nicotine vs. ethanol discrimination: extinction and spontaneous recovery of responding.

Authors:  Joseph R Troisi
Journal:  Integr Physiol Behav Sci       Date:  2003 Apr-Jun
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.